Aseptic meningitis and leptomeningeal enhancement associated with anti-MOG antibodies: A review

2021 ◽  
pp. 577653
Author(s):  
Grace Y. Gombolay ◽  
Judith A. Gadde
2020 ◽  
Vol 41 (9) ◽  
pp. 2635-2638 ◽  
Author(s):  
Eiichiro Amano ◽  
Akira Machida ◽  
Naomi Kanazawa ◽  
Takahiro Iizuka

Neurology ◽  
1998 ◽  
Vol 51 (2) ◽  
pp. 614-617 ◽  
Author(s):  
S. V. Kothare ◽  
C.-C. Chu ◽  
K. VanLandingham ◽  
K. C. Richards ◽  
D. A. Hosford ◽  
...  

We report a case of relapsing polychondritis with focal sensorimotor seizures, aseptic meningitis, and migratory leptomeningeal enhancement on contrast MRI. These abnormalities on imaging studies correlated accurately with laterality of the patient's seizures, facilitating early aggressive management of his neurologic symptoms.


2021 ◽  
Vol 36 (11) ◽  
pp. 1042-1046
Author(s):  
Judith A. Gadde ◽  
David S. Wolf ◽  
Stephanie Keller ◽  
Grace Y. Gombolay

Introduction: Myelin oligodendrocyte glycoprotein antibodies (MOG-abs) are associated with demyelinating diseases. Leptomeningeal enhancement occurs in 6% of adult MOG-abs patients but rates in pediatric MOG-abs patients are unknown. Methods: Retrospective review of pediatric MOG-abs patients was performed. Results: Twenty-one patients (7 boys, 14 girls) were included with an average age of 8.6 years (range 2-15 years). Seven of 21 (33%) pediatric MOG-abs patients had leptomeningeal enhancement. Two patients’ relapses were manifested by leptomeningeal enhancement alone and another patient presented with seizures, encephalopathy, and aseptic meningitis without demyelinating lesions. Cerebrospinal fluid pleocytosis was seen in both leptomeningeal (4/7 patients) and nonleptomeningeal enhancement (10/14 patients). Interestingly, 3 patients with leptomeningeal enhancement had normal cerebrospinal fluid white blood cell count. Cortical edema was more likely in patients with leptomeningeal enhancement ( P = .0263). Conclusion: We expand the clinical spectrum of anti-MOG antibody–associated disorder. Patients with recurrent leptomeningeal enhancement without demyelinating lesions should be tested for MOG antibodies.


1974 ◽  
Vol 110 (5) ◽  
pp. 771-772 ◽  
Author(s):  
M. Jarratt

2020 ◽  
Vol 72 (2) ◽  
Author(s):  
Marco Rossi ◽  
Paolo Siani ◽  
Adriano Grossi ◽  
Novella Carannante ◽  
Giovanni Di Caprio ◽  
...  

Author(s):  
Sameer Peer ◽  
Vivek Murumkar ◽  
Karthik Kulanthaivelu ◽  
Chandrajit Prasad ◽  
Shilpa Rao ◽  
...  

Abstract Background Diffuse leptomeningeal glioneuronal tumor (DLGNT) has been recently described in the literature. The complete neuroimaging spectrum and histopathological characteristics of this entity are yet to be elucidated. In an endemic region, diffuse leptomeningeal enhancement on neuroimaging with associated communicating hydrocephalus is usually suggestive of infective meningitis and the patients are started on empirical anti-microbial therapy. However, it is important to consider other differential diagnosis of leptomeningeal enhancement in such cases, particularly if the clinical condition does not improve on anti-microbial therapy. An early diagnosis of a neoplastic etiology may be of particular importance as the treatment regimens vary considerably depending on the underlying disease condition. Case presentation In this case report, we describe a case of DLGNT with high-grade histopathological features which was initially managed as tubercular meningitis based on the initial neuroimaging findings. Due to worsening of the clinical course and subsequent imaging findings at follow-up, a diagnosis of DLGNT was considered and subsequently proven to be DLGNT with features of anaplasia on histopathological examination of leptomeningeal biopsy specimen. Conclusion This case highlights the importance of recognizing certain subtle finding on MRI which may help in an early diagnosis of DLGNT which is crucial for appropriate treatment.


Sign in / Sign up

Export Citation Format

Share Document